Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population July 23, 2025

Meeting | Mixed

---

• Date: July 23, 2025
• Time: 9:00 a.m. - 4:00 p.m. ET

The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, will convene a hybrid public meeting to gather input on the clinical use and safety concerns associated with orally ingestible unapproved prescription drug products containing fluoride for use in children.

---

Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31, Great Room, Silver Spring, MD 20993-0002. There will be limited seating for the public.

Registration: 

• Register to Attend In-Person.
• Register to Attend Virtually.